Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

This study has been terminated.
(Due to financial reasons)
Sponsor:
Information provided by (Responsible Party):
Neurologix, Inc.
ClinicalTrials.gov Identifier:
NCT00643890
First received: March 24, 2008
Last updated: February 20, 2012
Last verified: February 2012